• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症负担指数与胸痛且无阻塞性冠状动脉病变患者冠状动脉慢血流现象的相关性。

Association between inflammatory burden index and coronary slow flow phenomenon in patients with chest pain and no obstructive coronary arteries.

机构信息

Department of Emergency Medicine, Shenzhen Luohu Hospital Group Luohu People's Hospital, The Third Affiliated Hospital of Shenzhen University, Shenzhen, China.

Department of Cardiology, Shenzhen Luohu Hospital Group Luohu People's, Hospital The Third Affiliated Hospital of Shenzhen University, Shenzhen, China.

出版信息

BMC Cardiovasc Disord. 2024 Oct 26;24(1):595. doi: 10.1186/s12872-024-04281-4.

DOI:10.1186/s12872-024-04281-4
PMID:39462315
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11515272/
Abstract

BACKGROUND

The inflammatory burden index (IBI), a novel inflammation-based indicator, to is associated with the presence and prognosis of various diseases. However, few studies have focused on exploring the relationship between IBI and the coronary slow flow phenomenon (CSFP). In this study, we aimed to investigate the predictive value of IBI for CSFP in patients with chest pain and no obstructive coronary artery disease.

METHODS

A total of 1126 individuals with chest pain and no obstructive coronary arteries were consecutively included in this study. 71 patients developed CSFP were included in the CSFP group. A 1:2 age- and sex-matched patient with normal blood flow and angiographically proven normal coronary arteries was selected as the control group (n = 142). Plasma C-reactive protein (CRP), neutrophil, and lymphocyte counts were measured to determine the value of IBI.

RESULTS

The IBI were significantly higher in the CSFP group than in the controls (21.1 ± 6.5 vs. 14.5 ± 6.4, P < 0.001). The IBI increasedelevated with the increase of the numbers of vessels affected by CSFP. Multivariate logistic regression analysis revealed that IBI and body mass index (BMI) were independent predictors of CSFP. Receiver operating characteristic (ROC) curve analysis showed that when IBI was > 15.74, the sensitivity and specificity were 77.5% and 67.6%, respectively, and the area under the ROC curve (AUC) was 0.799 (95% CI: 0.737-0.862, P<0.001).

CONCLUSION

The IBI may be an independent predictor of CSFP in patients with chest pain and normal coronary arteries. The IBI could improve the predictive value of CSFP compared with the indicators alone.

摘要

背景

炎症负担指数(IBI)是一种新的基于炎症的指标,与各种疾病的存在和预后相关。然而,很少有研究关注 IBI 与冠状动脉慢血流现象(CSFP)之间的关系。本研究旨在探讨 IBI 对胸痛且无阻塞性冠状动脉疾病患者 CSFP 的预测价值。

方法

本研究连续纳入 1126 例胸痛且无阻塞性冠状动脉的患者。其中 71 例发生 CSFP 的患者纳入 CSFP 组,选择年龄和性别匹配的 1:2 例血流正常且经血管造影证实正常的冠状动脉患者作为对照组(n=142)。测定血浆 C 反应蛋白(CRP)、中性粒细胞和淋巴细胞计数,以确定 IBI 的价值。

结果

CSFP 组的 IBI 明显高于对照组(21.1±6.5 比 14.5±6.4,P<0.001)。随着 CSFP 受累血管数量的增加,IBI 升高。多变量 logistic 回归分析显示,IBI 和体重指数(BMI)是 CSFP 的独立预测因子。受试者工作特征(ROC)曲线分析显示,当 IBI>15.74 时,敏感性和特异性分别为 77.5%和 67.6%,ROC 曲线下面积(AUC)为 0.799(95%CI:0.737-0.862,P<0.001)。

结论

IBI 可能是胸痛且无阻塞性冠状动脉疾病患者 CSFP 的独立预测因子。与单独的指标相比,IBI 可以提高 CSFP 的预测价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/608d/11515272/def6e8bc8445/12872_2024_4281_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/608d/11515272/3720e94e2cfe/12872_2024_4281_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/608d/11515272/f6740f9662fc/12872_2024_4281_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/608d/11515272/def6e8bc8445/12872_2024_4281_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/608d/11515272/3720e94e2cfe/12872_2024_4281_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/608d/11515272/f6740f9662fc/12872_2024_4281_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/608d/11515272/def6e8bc8445/12872_2024_4281_Fig3_HTML.jpg

相似文献

1
Association between inflammatory burden index and coronary slow flow phenomenon in patients with chest pain and no obstructive coronary arteries.炎症负担指数与胸痛且无阻塞性冠状动脉病变患者冠状动脉慢血流现象的相关性。
BMC Cardiovasc Disord. 2024 Oct 26;24(1):595. doi: 10.1186/s12872-024-04281-4.
2
Uric acid to albumin ratio as a novel predictor for coronary slow flow phenomenon in patients with chronic coronary syndrome and non-obstructive coronary arteries.尿酸与白蛋白比值作为慢性冠状动脉综合征伴非阻塞性冠状动脉疾病患者冠状动脉慢血流现象的新型预测因子。
BMC Cardiovasc Disord. 2024 Jul 13;24(1):358. doi: 10.1186/s12872-024-04040-5.
3
Could Pan-Immune-Inflammation Value be a Marker for the Diagnosis of Coronary Slow Flow Phenomenon?全免疫炎症值能否成为冠状动脉慢血流现象诊断的标志物?
Cardiovasc Toxicol. 2024 May;24(5):519-526. doi: 10.1007/s12012-024-09855-4. Epub 2024 Apr 15.
4
Coronary slow flow--prevalence and clinical correlations.冠状动脉慢血流——患病率及临床相关性。
Circ J. 2012;76(4):936-42. doi: 10.1253/circj.cj-11-0959. Epub 2012 Feb 1.
5
Clinical characteristics in patients with coronary slow flow phenomenon: A retrospective study.冠状动脉慢血流现象患者的临床特征:一项回顾性研究。
Medicine (Baltimore). 2021 Feb 12;100(6):e24643. doi: 10.1097/MD.0000000000024643.
6
Association between increased serum alkaline phosphatase and the coronary slow flow phenomenon.血清碱性磷酸酶升高与冠状动脉慢血流现象之间的关联。
BMC Cardiovasc Disord. 2018 Jul 4;18(1):138. doi: 10.1186/s12872-018-0873-6.
7
Relationship between increased systemic immune-inflammation index and coronary slow flow phenomenon.全身免疫炎症指数与冠状动脉慢血流现象的关系。
BMC Cardiovasc Disord. 2022 Aug 8;22(1):362. doi: 10.1186/s12872-022-02798-0.
8
Asymmetric Dimethylarginine Is Associated with the Phenomenon of Coronary Slow Flow in Patients with Nonvalvular Atrial Fibrillation.非瓣膜性心房颤动患者不对称二甲基精氨酸与冠状动脉慢血流现象相关。
Cardiology. 2024;149(3):208-216. doi: 10.1159/000536024. Epub 2024 Jan 20.
9
Incremental value of three-dimensional echocardiography for evaluating left atrial function in patients with coronary slow flow phenomenon: a case control study.三维超声心动图评估冠状动脉慢血流现象患者左心房功能的增量价值:一项病例对照研究
Cardiovasc Ultrasound. 2020 Feb 13;18(1):6. doi: 10.1186/s12947-020-00189-z.
10
Clinical and laboratory predictors of coronary slow flow in coronary angiography.冠状动脉造影中冠状动脉血流缓慢的临床及实验室预测指标
Perfusion. 2017 Jan;32(1):13-19. doi: 10.1177/0267659116659918. Epub 2016 Jul 19.

引用本文的文献

1
The relationship between hematological parameters such as eosinophil-basophil levels, eosinophil-to-basophil ratio, monocyte-to-basophil ratio, and the coronary slow flow phenomenon.嗜酸性粒细胞-嗜碱性粒细胞水平、嗜酸性粒细胞与嗜碱性粒细胞比值、单核细胞与嗜碱性粒细胞比值等血液学参数与冠状动脉慢血流现象之间的关系。
Medicine (Baltimore). 2025 Aug 8;104(32):e43819. doi: 10.1097/MD.0000000000043819.
2
Inflammatory Burden Index Associated with Recurrence of Atrial Fibrillation After Radiofrequency Catheter Ablation.射频导管消融术后与心房颤动复发相关的炎症负荷指数
Ther Clin Risk Manag. 2025 May 15;21:681-689. doi: 10.2147/TCRM.S518620. eCollection 2025.
3

本文引用的文献

1
Could Pan-Immune-Inflammation Value be a Marker for the Diagnosis of Coronary Slow Flow Phenomenon?全免疫炎症值能否成为冠状动脉慢血流现象诊断的标志物?
Cardiovasc Toxicol. 2024 May;24(5):519-526. doi: 10.1007/s12012-024-09855-4. Epub 2024 Apr 15.
2
Prognostic Value of Inflammatory Burden Index in Advanced Gastric Cancer Patients Undergoing Multimodal Treatment.炎症负荷指数在接受多模式治疗的晚期胃癌患者中的预后价值
Cancers (Basel). 2024 Feb 18;16(4):828. doi: 10.3390/cancers16040828.
3
Clinical Significance of the Preoperative Inflammatory Burden Index in Esophageal Cancer.
Advanced Lung Cancer Inflammation Index as a Predictor of Coronary Slow Flow Phenomenon in Patients with Angina and Non-Obstructive Coronary Arteries.
晚期肺癌炎症指数作为心绞痛和非阻塞性冠状动脉患者冠状动脉慢血流现象的预测指标
Int J Gen Med. 2025 May 9;18:2497-2505. doi: 10.2147/IJGM.S522261. eCollection 2025.
4
Association and Predictive Ability between Inflammatory Burden Index and Fever Following Endobronchial Forceps Biopsy in Lung Cancer Patients.肺癌患者支气管内钳取活检后炎症负荷指数与发热之间的关联及预测能力
J Inflamm Res. 2025 May 2;18:5911-5922. doi: 10.2147/JIR.S521144. eCollection 2025.
5
The Global Immune-Nutrition Inflammation Index for Predicting Coronary Slow Flow Phenomenon in Patients with Angina and No Obstructive Coronary Arteries.用于预测心绞痛且无阻塞性冠状动脉患者冠状动脉慢血流现象的全球免疫营养炎症指数
Int J Gen Med. 2025 Mar 7;18:1325-1332. doi: 10.2147/IJGM.S516108. eCollection 2025.
术前炎症负担指数在食管癌中的临床意义。
Oncology. 2024;102(7):556-564. doi: 10.1159/000535727. Epub 2023 Dec 22.
4
Association between inflammatory burden index and all-cause mortality in the general population aged over 45 years: Data from NHANES 2005-2017.炎症负担指数与 45 岁以上人群全因死亡率的关系:来自 NHANES 2005-2017 的数据。
Nutr Metab Cardiovasc Dis. 2024 Jan;34(1):64-74. doi: 10.1016/j.numecd.2023.10.006. Epub 2023 Oct 10.
5
Assessment of the relationship between plasma fibrinogen-to-albumin ratio and slow coronary flow phenomenon in patients without obstructive coronary artery disease.评估无阻塞性冠状动脉疾病患者血浆纤维蛋白原-白蛋白比值与慢血流现象之间的关系。
BMC Cardiovasc Disord. 2023 Nov 6;23(1):540. doi: 10.1186/s12872-023-03579-z.
6
Inflammatory Burden Index: Association Between Novel Systemic Inflammatory Biomarkers and Prognosis as Well as in-Hospital Complications of Patients with Aneurysmal Subarachnoid Hemorrhage.炎症负担指数:新型全身炎症生物标志物与动脉瘤性蛛网膜下腔出血患者预后及院内并发症之间的关联
J Inflamm Res. 2023 Sep 4;16:3911-3921. doi: 10.2147/JIR.S416295. eCollection 2023.
7
Association Between Inflammatory Burden Index and Unfavorable Prognosis After Endovascular Thrombectomy in Acute Ischemic Stroke.急性缺血性卒中血管内血栓切除术后炎症负担指数与不良预后的关系
J Inflamm Res. 2023 Jul 19;16:3009-3017. doi: 10.2147/JIR.S419087. eCollection 2023.
8
Relationship between inflammatory markers and coronary slow flow in type 2 diabetic patients.2 型糖尿病患者炎症标志物与冠状动脉慢血流的关系。
BMC Cardiovasc Disord. 2023 May 9;23(1):244. doi: 10.1186/s12872-023-03275-y.
9
The inflammatory burden index is a superior systemic inflammation biomarker for the prognosis of non-small cell lung cancer.炎症负担指数是预测非小细胞肺癌预后的一种更优的系统性炎症生物标志物。
J Cachexia Sarcopenia Muscle. 2023 Apr;14(2):869-878. doi: 10.1002/jcsm.13199. Epub 2023 Feb 28.
10
Prognostic Value of Inflammation-Immunity-Nutrition Score and Inflammatory Burden Index for Hepatocellular Carcinoma Patients After Hepatectomy.炎症-免疫-营养评分及炎症负荷指数对肝癌肝切除术后患者的预后价值
J Inflamm Res. 2022 Nov 28;15:6463-6479. doi: 10.2147/JIR.S386407. eCollection 2022.